[Anesthesia in cats using tiletamine/zolazepam in minimal doses]. / Zur Anästhesie bei der Katze mit Tiletamin/Zolazepam in Minimaldosierung.

The object of this study was to evaluate minimal dose anesthesia with Tiletamine/Zolazepam for castration, dental treatments and other minor surgical procedures in cats. The study included 264 cats treated either at the Department of Veterinary Surgery, Ludwig-Maximilians University of Munich or under private practice conditions, in a small animal clinic in Hamburg (Germany). The drug dose needed for anesthesia for a 10 minute surgical procedure was calculated in each case using a formula. Side effects that occurred with doses recommended by the manufacturer could not be eliminated by decreasing the drug dose, but could be reduced considerably in severity and duration. Tiletamine/Zolazepam was found to be a useful drug for short anesthesia in cats at an average dose of 4.2 mg/kg.

[Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)]. / Prophylaxe der Rhesus-Sensibilisierung durch intravenöse Gabe von Immunglobulin G Anti-D

During 1971 and 1972 1109 rh-negative mothers with an Rh-positive child were treated with an intravenous standard dose of 80-120 microng of IgG anti-D. To achieve complete elimination of fetal erythrocytes within 72 hours after the first immunoglobulin injection this standard dose had to be increased in 14% of the women. In 1973 and 1974 1138 rh-negative mothers of Rh-positive children were treated with an intravenous standard dose of 240 microng of IgG anti-D. This dose was insufficient in only 1.2% of the rh-negative mothers. More than 98.8% of all women are protected by a standard intravenous dose of 240 microng of IgG anti-D and a single erythrocyte elimination control 72 hours after the birth. It appears that the results after intravenous immunoglobulin are as a whole significantly better than after intramuscular IgG anti-D.

[Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)]. / Prophylaxe der Rhesus-Sensibilisierung durch intravenöse Gabe von Immunglobulin G Anti-D

Intravenously administered IgG anti-D permits a prophylatic rhesus sensitization. The size of the dose of immunoglobulin is adapted to the fetomaternal blood transfusion. The procedure is highly reliable in individual cases. The results acquired from a large control group, however, are not significantly better than the results obtained by other authors with intramuscular administration of IgG anti-D. Of the 1216 rh-negative mothers who were given follow-up checks, 1208 showed no active D-antibody formation as late as 7 months postpartum. An active D-antibody formation was found in 8 rh-negative mothers up to 14 days postpartum. These were anamnestic reactions. In 212 second pregnancies with a rh-postive child, 2 rh-negative mothers were sensitized in the rhesus system. The cause of this failure is thought to be the fact that the intravenously administered IgG anti-D did not gain access to the noncirculating D-positive erythrocytes in the pertioneal cavity of the mother.